Posts Tagged ‘gene therapy ankylosing spondylitis’
Conventional therapies such as chemotherapy and hormonal therapy, but control of the progression of the disease, often associated with side effects. For example, the side effects caused by chemotherapy in cancer range from nausea and hair loss of thrombocytopenia and neutropenia.
Patients often succumb to death due to side effects and cancer.Chemotherapy does not possess the characteristics of the target selectively.Once administered, inducing a systemic action throughout the body that lead to these potential side effects.
Targeted therapies such as monoclonal antibodies have so far shown better efficacy and safety profiles compared with chemotherapy. However, in reality they do not induce complete remission of the disease. Or reduce the signs and symptoms of the disease or slow tumor growth. The inability of these therapies to cure diseases has created significant unmet needs in cancer diseases, diseases of hepatitis, HIV and autoimmune diseases.
Many market Avastin as monoclonal antibodies, rituximab, and Remicade are approved for several indications lead to increased opportunities for patient base for these products. Alemtuzumab, approved B-cell chronic lymphocytic leukemia, is in Phase III clinical trials of multiple sclerosis. REMICADE is approved for the treatment of plaque psoriasis, rheumatoid arthritis, psoriatic arthritis.
Crohn’s disease in adults, pediatric Crohn’s disease, ulcerative colitis and ankylosing spondylitis. REMICADE is also in Phase III clinical trials for the treatment of juvenile rheumatoid arthritis and in Phase II clinical trials for the treatment of sarcoidosis, chronic obstructive pulmonary disease (COPD), cachexia, and asthma.
Enbrel was approved to treat rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.GBI investigation, the leading provider of business intelligence, has released its latest study, “Targeted Therapeutics Advancement in Gene Therapy and Stem Cell Therapy Market to run.”
It provides key information, data, and analyzes the main types of targeted therapies and key pipeline molecules. Report of the whole profile of the key promising therapies in the pipeline. Report a comprehensive analysis of the key M & A and licensing agreements with major companies and analyzes the results of each deal. It also analyzes regulatory strategies in a scenario of gene therapy and stem cell therapy.